Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$12,559,604
+$2,048,095 QoQ
Shares Held
49,911
+3.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#804
of 4,153 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LGT Fund Management Co Ltd. holds $166,987,121 across 7 Drug Manufacturers - General names. ABBV ranks #5 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
58,755 | $70,472,515 | |
| 2 | JNJ |
Johnson & Johnson
|
116,198 | $29,510,806 | |
| 3 | AZN |
Astrazeneca PLC
|
139,758 | $26,500,911 | |
| 4 | PFE |
Pfizer Inc
|
857,783 | $20,655,414 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
49,911 | $12,559,604 | |
| 6 | MRK |
Merck & Co., Inc.
|
39,522 | $5,078,577 | |
| 7 | AMGN |
Amgen Inc
|
6,101 | $2,209,294 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,559,604 | 49,911 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $10,511,509 | 48,331 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $2,279,187 | 9,975 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $2,675,213 | 11,554 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,924,508 | 10,368 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $3,133,162 | 14,954 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,774,170 | 21,239 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $799,991 | 4,051 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $443,207 | 2,584 | Shares | Defined | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||